Sermorelin calculators

This hub gathers the four Sermorelin calculators in one place — reconstitution, dose, mg ↔ units, and vial duration — pre-filled with a 5 mg / 2 mL example so the math is concrete the moment the page loads. Sermorelin sits in the GH Secretagogue category, and the numbers each tool surfaces are tuned to how people actually log this peptide: a daily shot at the 0.2 mcg example dose. A 29-amino-acid GHRH analog studied since the 1970s for its short-acting pituitary stimulation.

At the example concentration of 2.5 mg/mL, a 0.2 mcg Sermorelin dose draws roughly 8 units on a U-100 insulin syringe — the Dose calculator on the hub shows that working in real time, and the mg ↔ units converter flips it back the other way for people who think in milligrams. The Reconstitution calculator answers the day-one question (how much bacteriostatic water to add and what concentration that gives), and the Vial Duration calculator answers the planning question (how many weeks one vial covers).

For this 5 mg Sermorelin vial, the example numbers imply about 25 doses per vial and roughly 3.6 weeks of coverage at 7 doses per week — that's the math the Vial Duration tool exposes, and it's the number most people use to decide when to reorder. Every calculator on the hub uses these same five inputs (vial mg, diluent mL, dose, doses-per-week, syringe type), so changing your real numbers in one tool gives consistent answers across the others.

Research protocols for Sermorelin are built around its very short half-life and the body's natural circadian rhythm of GH secretion. Administration is frequently scheduled as a single subcutaneous injection per day, timed shortly before bedtime. This approach is intended to have the peptide's activity coincide with the largest natural GH pulse of the day, which occurs during the first few hours of slow-wave sleep. The goal is to augment this existing nocturnal pulse rather than to create an independent secretory event at another time.

A U-100 insulin syringe is the instrument typically used for subcutaneous administration, with the cadence in example protocols often set at seven times per week for consistency. The choice of a pre-sleep injection time is a deliberate strategy to align the peptide's stimulus with the body's endogenous endocrine schedule. The entire protocol structure is designed around Sermorelin's identity as a short-acting GHRH mimetic, leveraging its rapid onset and clearance to work in concert with natural pituitary function.

Protocols detailed in published literature frequently document a specific administration cadence tied to the sleep cycle. A common approach studied involves a single daily administration scheduled immediately before bedtime. This timing is methodically chosen to coincide with the body's primary endogenous GH pulse, which occurs during the first few hours of deep sleep. For personal data tracking purposes, documenting the precise time of administration relative to sleep onset is a critical variable to record. For instance, an individual following a daily cadence might calculate a 200 mcg illustrative dose from a 5 mg vial reconstituted with 2 mL, which involves drawing 0.08 mL or 8 units on a U-100 syringe.